稳定的小儿肝移植受者在两年后从山地明转换为新山地明的结果。 - Suppr | 超能文献

Results of conversion from Sandimmune to Neoral in stable pediatric liver transplant recipients after two years.

作者信息

Dunn S P, Falkenstein K, Pierson A, Cooney G F

机构信息

Department of Surgery, St Christophers Hospital for Children, Philadelphia, Pennsylvania, USA.

出版信息

Transplant Proc. 1998 Aug;30(5):1962-3. doi: 10.1016/s0041-1345(98)00496-5.

DOI:10.1016/s0041-1345(98)00496-5

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Results of conversion from Sandimmune to Neoral in stable pediatric liver transplant recipients after two years.稳定的小儿肝移植受者在两年后从山地明转换为新山地明的结果。

Transplant Proc. 1998 Aug;30(5):1962-3. doi: 10.1016/s0041-1345(98)00496-5.

2

Safety of conversion from cyclosporine Sandimmune to cyclosporine Neoral in stable liver transplant patients.稳定期肝移植患者从环孢素（山地明）转换为环孢素（新山地明）的安全性。

Transplant Proc. 1998 Aug;30(5):1852-3. doi: 10.1016/s0041-1345(98)00455-2.

3

Conversion from the conventional cyclosporine formulation (Sandimmune) to a new oral microemulsion (Neoral) in stable liver transplant patients.稳定期肝移植患者从传统环孢素制剂（山地明）转换为新型口服微乳剂（新山地明）的情况。

Transplant Proc. 1998 Aug;30(5):1857. doi: 10.1016/s0041-1345(98)00458-8.

4

Conversion from Sandimmune to Neoral in stable liver graft recipients.

Transplant Proc. 1996 Aug;28(4):2244-6.

5

NOF-11: a one-year randomized double-blind comparison of Neoral versus Sandimmune in pediatric liver transplantation.NOF - 11：新山地明与环孢素在小儿肝移植中的一年期随机双盲比较。

Transplant Proc. 1998 Aug;30(5):1961. doi: 10.1016/s0041-1345(98)00495-3.

6

Increased dosage requirement and rejection after Neoral conversion in pediatric liver transplant patients.小儿肝移植患者在转换为新山地明（Neoral）治疗后剂量需求增加及出现排斥反应。

Transplant Proc. 1998 Dec;30(8):4322-4. doi: 10.1016/s0041-1345(98)01426-2.

7

Potential role of Neoral in pediatric liver transplantation.新山地明（环孢素软胶囊）在小儿肝移植中的潜在作用

Transplant Proc. 1996 Aug;28(4):2267-9.

8

Neoral as the initial immunosuppressant in liver transplantation; conversion from Sandimmune to Neoral in stable patients.新山地明作为肝移植中的初始免疫抑制剂；稳定患者从环孢素转换为新山地明。

Transplant Proc. 1998 Nov;30(7):3537-8. doi: 10.1016/s0041-1345(98)01127-0.

9

Successful reconversion from tacrolimus to cyclosporine A Neoral in pediatric liver recipients.

Transplant Proc. 1996 Aug;28(4):2276-8.

10

Reduced acute rejection after liver transplantation with Neoral-based double immunosuppression.采用以新山地明为基础的双重免疫抑制方案后肝移植急性排斥反应减少。

Transplant Proc. 1998 Aug;30(5):1855-6. doi: 10.1016/s0041-1345(98)00457-6.

引用本文的文献

1

Cyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (neoral)1 in organ transplantation.环孢素：基于微乳剂的制剂（新山地明）在器官移植中药物动力学特性、临床疗效及耐受性的最新综述

Drugs. 2001;61(13):1957-2016. doi: 10.2165/00003495-200161130-00006.